pre-seed
Stage
1
Investors
About
Vascugen develops regenerative medicine therapies using induced pluripotent stem cell technology to restore blood flow by forming new blood vessels, targeting vascular degenerative diseases such as critical limb ischemia and diabetic retinopathy.
Explore Vascugen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.